Anna Bruckner, MD

Anna Bruckner, MD, is a pediatric dermatologist, a professor of dermatology and pediatrics at the University of Colorado School of Medicine, and section head of pediatric dermatology and co-director of the Epidermolysis Bullosa Center of Excellence at Children’s Hospital Colorado.

Articles by Anna Bruckner, MD

Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD

ByTim Smith,Anna Bruckner, MD

February 13th 2025

This interview highlights the significance of Bruckner’s recent phase 3 data on birch triterpenes as a potential treatment for dystrophic and junctional EB, as well as patients’ unmet needs.

Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD

ByTim Smith,Anna Bruckner, MD

February 12th 2025

Bruckner discusses her team’s long-term data on the safety and efficacy of birch bark extract, also known as Oleogel-S10, for those with epidermolysis bullosa.

Latest Updated Articles

Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD
February 12th 2025

Anna Bruckner, MD

Articles by Anna Bruckner, MD

Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD

Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD

Latest Updated Articles

Trending on HCPLive

TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight

TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo

What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD

Berobenatide Monthly Dosing Shows Weight Loss Efficacy in VESPER Trials, With John Buse, MD, PhD

CONNECT Trial Backs CGM for Non-Insulin Type 2 Diabetes Management